Management of Vomiting
Ondansetron is the first-line agent for managing vomiting, with a recommended dosage of 8 mg orally/sublingually every 4-6 hours during episodes of vomiting. 1, 2
First-Line Pharmacological Management
- Ondansetron (5-HT3 receptor antagonist) is the preferred first-line agent due to its superior efficacy and fewer side effects at a dose of 8 mg orally/sublingually every 4-6 hours 1, 2
- Metoclopramide is an alternative first-line option at 10-20 mg orally three to four times daily, working through both central and peripheral pathways 1, 3
- For persistent vomiting, routine around-the-clock administration rather than PRN dosing is more effective 4
Second-Line Options
- Prochlorperazine can be used at 5-10 mg every 6-8 hours or 25 mg suppository every 12 hours when first-line agents are ineffective 4, 5
- Promethazine is an option at 12.5-25 mg oral/rectal every 4-6 hours, but is more sedating than other antiemetics 1, 4
- For breakthrough vomiting, adding an agent from a different drug class than what was used initially is recommended 6
Special Considerations for Different Causes
Chemotherapy-Induced Vomiting
- For high emetic risk chemotherapy, use a three-drug regimen: 5-HT3 antagonist + dexamethasone + neurokinin-1 antagonist 6, 1
- For moderate emetic risk chemotherapy, use a two-drug regimen: 5-HT3 antagonist + dexamethasone 6, 1
Radiation-Induced Vomiting
- For total body irradiation or high-dose radiotherapy to the abdomen, ondansetron 8 mg administered 1.5 hours before each fraction of radiotherapy is significantly more effective than placebo 6, 2
- For daily fractionated radiotherapy, ondansetron 8 mg is more effective than prochlorperazine 2
Non-Specific or Persistent Vomiting
- For persistent nausea and vomiting, consider adding 5-HT3 receptor antagonists, anticholinergic agents, antihistamines, corticosteroids, or continuous infusion of antiemetics 6
- Dronabinol and nabilone (cannabinoids) are FDA-approved for patients whose nausea and vomiting have not responded to conventional antiemetics 6
Supportive Care Measures
- Ensure adequate hydration and fluid repletion; consider IV fluids if dehydration is present 6, 7
- Check and correct electrolyte abnormalities 6, 4
- Consider antacid therapy (proton pump inhibitors, H2 blockers) for patients with difficulty distinguishing heartburn from nausea 6
- For gastric outlet obstruction, consider treatment with corticosteroids or endoscopic stenting 6
Important Considerations and Cautions
- Monitor for QT prolongation with ondansetron, especially in patients with cardiac risk factors 1, 2
- Avoid antiemetics in children with gastroenteritis as vomiting will usually subside as oral rehydration therapy is continued 8
- For pediatric patients, ondansetron (0.15-0.2 mg/kg) is indicated in children unable to take oral fluids due to persistent vomiting 9
- Be vigilant for red flag signs such as bilious or bloody vomiting, altered mental status, or severe dehydration, which require immediate evaluation 9
Alternative Approaches
- Consider alternative therapies such as acupuncture or hypnosis for refractory cases 6
- Palliative sedation can be considered as a last resort if intensified efforts by specialized palliative care or hospice services fail 6
Remember that the most effective approach to managing vomiting is to identify and treat the underlying cause while providing appropriate symptomatic relief with antiemetics and supportive care.